Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice

Helen Close1, James M Mason1, Douglas W Wilson1

  • 1School of Medicine, Pharmacy and Health, Durham University, Stockton-on-Tees, United Kingdom.

Plos One
|October 14, 2015
PubMed

Insights

Ischaemic heart disease (IHD) prevalence is higher in patients with inflammatory bowel disease (IBD), but most IHD diagnoses occur before IBD diagnosis. This suggests a complex relationship between IBD and IHD beyond shared inflammation.

Area of Science:

  • Cardiovascular Medicine
  • Gastroenterology
  • Epidemiology

Background:

  • Inflammatory bowel disease (IBD) shares inflammatory pathways with ischaemic heart disease (IHD).
  • The precise association between IBD and IHD remains unclear.
  • Understanding this relationship is crucial for patient management.

Purpose of the Study:

  • To investigate the extent and direction of the association between IBD and IHD.
  • To determine if IBD increases the risk of developing IHD.

Main Methods:

  • Retrospective cohort study using the General Practice Research Database (1987-2009).
  • Matched 19,163 IBD patients (≥15 years) with 75,735 controls without IBD.
  • Primary outcome: hazard ratio for IHD.

Main Results:

  • Higher IHD prevalence in IBD patients (11.6%) versus controls (8.6%).
  • Majority of IHD diagnoses (51.5%) preceded IBD diagnosis.
  • Increased IHD risk observed in the first year post-IBD diagnosis, particularly for Ulcerative Colitis (UC) patients.

Conclusions:

  • While IHD prevalence is higher in IBD patients, most IHD diagnoses occur before IBD.
  • The relationship between IBD and IHD is more complex than a simple inflammatory link.
  • Alternative etiological models for IHD in IBD patients should be explored.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
915
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
947
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
848